Tag: disease registry software market size

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Disease Registry Software Market CAGR Analysis And Future Market Development

The marketplace for disease registry software has experienced a significant upswing. Projections indicate a substantial expansion, with the market value set to increase from $1.55 billion in 2025 to $1.73 billion in 2026, demonstrating a compound annual growth rate of 11.4%. Key factors fueling this growth during the past period include the widespread adoption of digital patient record-keeping, the proliferation of research initiatives focused on specific ailments, escalating demands for regulatory compliance reporting, the integration of electronic health records, and the increasing reliance on analytical tools to inform clinical choices.

The market for disease registry software is poised for substantial expansion, projecting a reach of $2.64 billion by 2030, fueled by an 11.1% compound annual growth rate. This projected increase is largely driven by a heightened need for population health analytics, the growing incorporation of AI for clinical insights, a wider embrace of cloud-based registry solutions, an intensified focus on value-based healthcare, and the increasing utilization of real-world data in clinical studies. Key developments anticipated during this period include a greater adoption of unified disease registry platforms, expanded use of cloud-based patient data management systems, a stronger emphasis on reporting data in accordance with regulations, the proliferation of registry solutions integrated with electronic health records, and a more pronounced effort in gathering real-world evidence.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28208&type=smp

Disease Registry Software Market Expansion Supported By Key Demand Factors

The trajectory of the disease registry software market is poised for expansion, largely fueled by the escalating utilization of personalized medicine. This approach to healthcare focuses on customizing treatment and preventative measures based on an individual’s distinct genetic profile, habits, and surroundings. The widespread embrace of personalized medicine stems primarily from breakthroughs in genomics, which facilitate the accurate detection of genetic differences and the development of individualized therapies. Disease registry software plays a pivotal role in enabling personalized medicine by efficiently gathering and organizing patient health information, thereby facilitating bespoke treatment regimens and more informed clinical choices. It simplifies the process of accessing and analyzing data, ultimately leading to better patient results and progress in precision medicine. A notable indicator of this trend is the U.S. Food and Drug Administration’s (FDA) approval of 26 new personalized medicines in 2023, a substantial rise from the 12 approvals in 2022, as reported in February 2024 by the Personalized Medicine Coalition (PMC), a non-profit entity based in the United States. Consequently, the expanding use of personalized medicine is a key impetus behind the growth observed in the disease registry software market.

Disease Registry Software Market Segment Breakdown: Which Categories Generate The Most Revenue?

The disease registry software market covered in this report is segmented –

1) By Type: Standalone, Integrated

2) By Database: Public, Commercial

3) By Deployment Mode: On-Premises, Cloud-Based

4) By End-User: Hospitals, Government Organizations, Research Centers, Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Standalone: Patient Registry Software, Population Health Registry Software, Research Registry Software, Custom Or Single-Disease Registry Software

2) By Integrated: Electronic Health Record (EHR)-Integrated Registry Software, Practice Management System-Integrated Registry Software, Clinical Decision Support (CDS)-Integrated Registry Software, Health Information Exchange (HIE)-Integrated Registry Software

Disease Registry Software Market Growth Trends Influencing Competitive Dynamics

Leading entities within the disease registry software sector are strategically prioritizing the creation of registries centered around the patient experience, incorporating digital solutions to monitor health results and facilitate tailored medical interventions. These digital registries are essentially electronic frameworks or software applications engineered for the organized acquisition, retention, and administration of patient health data, thereby superseding outdated paper-based record-keeping. As an illustration, in August 2025, the American College of Cardiology (ACC), a non-profit medical organization based in the United States, introduced the CONNECT-HCM Registry. This particular initiative represents a national digital registry developed with the aim of enhancing the comprehension and management of hypertrophic cardiomyopathy (HCM), which is recognized as the most prevalent inherited heart condition. The registry facilitates the direct inclusion of patients from a broader geographical scope than just individual medical facilities, effectively bridging persistent deficiencies in diagnosis and treatment. This system integrates registry information with electronic health records through the utilization of Arboretum’s Hugo Connect platform, empowering researchers to meticulously follow symptoms, diagnostic imagery, treatment modalities, and patient prognoses over extended periods.

Disease Registry Software Market Key Players And Strategic Industry Positioning

Major companies operating in the disease registry software market are Optum Inc., IQVIA Holdings Inc., Syneos Health Inc., Epic Systems Corporation, Premier Inc., MRO Corp., ImageTrend Inc., Anju Software Inc., BayaTree Inc., Medrio Inc., ArborMetrix Inc., Cedaron Medical Inc., Evado Pty. Ltd., OpenClinica LLC, Dacima Software Inc., Global Vision Technologies Inc., Ordinal Data Inc., Healthmonix LLC, Axis Clinical Software Inc., Vanderbilt University

Access The Complete Disease Registry Software Market Report:

https://www.thebusinessresearchcompany.com/report/disease-registry-software-global-market-report

Disease Registry Software Market Regional Outlook: Where Are The Largest Opportunities Located?

North Americawas the largest region in the disease registry software market in 2025. The regions covered in the disease registry software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Disease Registry Software Market CAGR Analysis And Future Market Development

The marketplace for disease registry software has experienced a significant upswing. Projections indicate a substantial expansion, with the market value set to increase from $1.55 billion in 2025 to $1.73 billion in 2026, demonstrating a compound annual growth rate of 11.4%. Key factors fueling this growth during the past period include the widespread adoption of digital patient record-keeping, the proliferation of research initiatives focused on specific ailments, escalating demands for regulatory compliance reporting, the integration of electronic health records, and the increasing reliance on analytical tools to inform clinical choices.

The market for disease registry software is poised for substantial expansion, projecting a reach of $2.64 billion by 2030, fueled by an 11.1% compound annual growth rate. This projected increase is largely driven by a heightened need for population health analytics, the growing incorporation of AI for clinical insights, a wider embrace of cloud-based registry solutions, an intensified focus on value-based healthcare, and the increasing utilization of real-world data in clinical studies. Key developments anticipated during this period include a greater adoption of unified disease registry platforms, expanded use of cloud-based patient data management systems, a stronger emphasis on reporting data in accordance with regulations, the proliferation of registry solutions integrated with electronic health records, and a more pronounced effort in gathering real-world evidence.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28208&type=smp

Disease Registry Software Market Expansion Supported By Key Demand Factors

The trajectory of the disease registry software market is poised for expansion, largely fueled by the escalating utilization of personalized medicine. This approach to healthcare focuses on customizing treatment and preventative measures based on an individual’s distinct genetic profile, habits, and surroundings. The widespread embrace of personalized medicine stems primarily from breakthroughs in genomics, which facilitate the accurate detection of genetic differences and the development of individualized therapies. Disease registry software plays a pivotal role in enabling personalized medicine by efficiently gathering and organizing patient health information, thereby facilitating bespoke treatment regimens and more informed clinical choices. It simplifies the process of accessing and analyzing data, ultimately leading to better patient results and progress in precision medicine. A notable indicator of this trend is the U.S. Food and Drug Administration’s (FDA) approval of 26 new personalized medicines in 2023, a substantial rise from the 12 approvals in 2022, as reported in February 2024 by the Personalized Medicine Coalition (PMC), a non-profit entity based in the United States. Consequently, the expanding use of personalized medicine is a key impetus behind the growth observed in the disease registry software market.

Disease Registry Software Market Segment Breakdown: Which Categories Generate The Most Revenue?

The disease registry software market covered in this report is segmented –

1) By Type: Standalone, Integrated

2) By Database: Public, Commercial

3) By Deployment Mode: On-Premises, Cloud-Based

4) By End-User: Hospitals, Government Organizations, Research Centers, Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Standalone: Patient Registry Software, Population Health Registry Software, Research Registry Software, Custom Or Single-Disease Registry Software

2) By Integrated: Electronic Health Record (EHR)-Integrated Registry Software, Practice Management System-Integrated Registry Software, Clinical Decision Support (CDS)-Integrated Registry Software, Health Information Exchange (HIE)-Integrated Registry Software

Disease Registry Software Market Growth Trends Influencing Competitive Dynamics

Leading entities within the disease registry software sector are strategically prioritizing the creation of registries centered around the patient experience, incorporating digital solutions to monitor health results and facilitate tailored medical interventions. These digital registries are essentially electronic frameworks or software applications engineered for the organized acquisition, retention, and administration of patient health data, thereby superseding outdated paper-based record-keeping. As an illustration, in August 2025, the American College of Cardiology (ACC), a non-profit medical organization based in the United States, introduced the CONNECT-HCM Registry. This particular initiative represents a national digital registry developed with the aim of enhancing the comprehension and management of hypertrophic cardiomyopathy (HCM), which is recognized as the most prevalent inherited heart condition. The registry facilitates the direct inclusion of patients from a broader geographical scope than just individual medical facilities, effectively bridging persistent deficiencies in diagnosis and treatment. This system integrates registry information with electronic health records through the utilization of Arboretum’s Hugo Connect platform, empowering researchers to meticulously follow symptoms, diagnostic imagery, treatment modalities, and patient prognoses over extended periods.

Disease Registry Software Market Key Players And Strategic Industry Positioning

Major companies operating in the disease registry software market are Optum Inc., IQVIA Holdings Inc., Syneos Health Inc., Epic Systems Corporation, Premier Inc., MRO Corp., ImageTrend Inc., Anju Software Inc., BayaTree Inc., Medrio Inc., ArborMetrix Inc., Cedaron Medical Inc., Evado Pty. Ltd., OpenClinica LLC, Dacima Software Inc., Global Vision Technologies Inc., Ordinal Data Inc., Healthmonix LLC, Axis Clinical Software Inc., Vanderbilt University

Access The Complete Disease Registry Software Market Report:

https://www.thebusinessresearchcompany.com/report/disease-registry-software-global-market-report

Disease Registry Software Market Regional Outlook: Where Are The Largest Opportunities Located?

North Americawas the largest region in the disease registry software market in 2025. The regions covered in the disease registry software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Disease Registry Software Market CAGR Analysis And Future Market Development

The marketplace for disease registry software has experienced a significant upswing. Projections indicate a substantial expansion, with the market value set to increase from $1.55 billion in 2025 to $1.73 billion in 2026, demonstrating a compound annual growth rate of 11.4%. Key factors fueling this growth during the past period include the widespread adoption of digital patient record-keeping, the proliferation of research initiatives focused on specific ailments, escalating demands for regulatory compliance reporting, the integration of electronic health records, and the increasing reliance on analytical tools to inform clinical choices.

The market for disease registry software is poised for substantial expansion, projecting a reach of $2.64 billion by 2030, fueled by an 11.1% compound annual growth rate. This projected increase is largely driven by a heightened need for population health analytics, the growing incorporation of AI for clinical insights, a wider embrace of cloud-based registry solutions, an intensified focus on value-based healthcare, and the increasing utilization of real-world data in clinical studies. Key developments anticipated during this period include a greater adoption of unified disease registry platforms, expanded use of cloud-based patient data management systems, a stronger emphasis on reporting data in accordance with regulations, the proliferation of registry solutions integrated with electronic health records, and a more pronounced effort in gathering real-world evidence.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28208&type=smp

Disease Registry Software Market Expansion Supported By Key Demand Factors

The trajectory of the disease registry software market is poised for expansion, largely fueled by the escalating utilization of personalized medicine. This approach to healthcare focuses on customizing treatment and preventative measures based on an individual’s distinct genetic profile, habits, and surroundings. The widespread embrace of personalized medicine stems primarily from breakthroughs in genomics, which facilitate the accurate detection of genetic differences and the development of individualized therapies. Disease registry software plays a pivotal role in enabling personalized medicine by efficiently gathering and organizing patient health information, thereby facilitating bespoke treatment regimens and more informed clinical choices. It simplifies the process of accessing and analyzing data, ultimately leading to better patient results and progress in precision medicine. A notable indicator of this trend is the U.S. Food and Drug Administration’s (FDA) approval of 26 new personalized medicines in 2023, a substantial rise from the 12 approvals in 2022, as reported in February 2024 by the Personalized Medicine Coalition (PMC), a non-profit entity based in the United States. Consequently, the expanding use of personalized medicine is a key impetus behind the growth observed in the disease registry software market.

Disease Registry Software Market Segment Breakdown: Which Categories Generate The Most Revenue?

The disease registry software market covered in this report is segmented –

1) By Type: Standalone, Integrated

2) By Database: Public, Commercial

3) By Deployment Mode: On-Premises, Cloud-Based

4) By End-User: Hospitals, Government Organizations, Research Centers, Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Standalone: Patient Registry Software, Population Health Registry Software, Research Registry Software, Custom Or Single-Disease Registry Software

2) By Integrated: Electronic Health Record (EHR)-Integrated Registry Software, Practice Management System-Integrated Registry Software, Clinical Decision Support (CDS)-Integrated Registry Software, Health Information Exchange (HIE)-Integrated Registry Software

Disease Registry Software Market Growth Trends Influencing Competitive Dynamics

Leading entities within the disease registry software sector are strategically prioritizing the creation of registries centered around the patient experience, incorporating digital solutions to monitor health results and facilitate tailored medical interventions. These digital registries are essentially electronic frameworks or software applications engineered for the organized acquisition, retention, and administration of patient health data, thereby superseding outdated paper-based record-keeping. As an illustration, in August 2025, the American College of Cardiology (ACC), a non-profit medical organization based in the United States, introduced the CONNECT-HCM Registry. This particular initiative represents a national digital registry developed with the aim of enhancing the comprehension and management of hypertrophic cardiomyopathy (HCM), which is recognized as the most prevalent inherited heart condition. The registry facilitates the direct inclusion of patients from a broader geographical scope than just individual medical facilities, effectively bridging persistent deficiencies in diagnosis and treatment. This system integrates registry information with electronic health records through the utilization of Arboretum’s Hugo Connect platform, empowering researchers to meticulously follow symptoms, diagnostic imagery, treatment modalities, and patient prognoses over extended periods.

Disease Registry Software Market Key Players And Strategic Industry Positioning

Major companies operating in the disease registry software market are Optum Inc., IQVIA Holdings Inc., Syneos Health Inc., Epic Systems Corporation, Premier Inc., MRO Corp., ImageTrend Inc., Anju Software Inc., BayaTree Inc., Medrio Inc., ArborMetrix Inc., Cedaron Medical Inc., Evado Pty. Ltd., OpenClinica LLC, Dacima Software Inc., Global Vision Technologies Inc., Ordinal Data Inc., Healthmonix LLC, Axis Clinical Software Inc., Vanderbilt University

Access The Complete Disease Registry Software Market Report:

https://www.thebusinessresearchcompany.com/report/disease-registry-software-global-market-report

Disease Registry Software Market Regional Outlook: Where Are The Largest Opportunities Located?

North Americawas the largest region in the disease registry software market in 2025. The regions covered in the disease registry software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Disease Registry Software Market From 2026 To 2030?

The disease registry software market has shown rapid expansion in recent years. This market is projected to increase from $1.55 billion in 2025 to $1.73 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.4%. Historically, this growth can be attributed to several factors including the rising digitization of patient records, the proliferation of disease-specific research programs, stricter regulatory reporting requirements, the wider adoption of electronic health records, and the increasing application of data-driven clinical decision tools.

The disease registry software market is anticipated to experience substantial expansion over the upcoming years, reaching a size of $2.64 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.1%. This expansion during the forecast period is fueled by several factors, including a heightened demand for population health analytics, greater integration with AI-driven clinical insights, the broader deployment of cloud-based registries, an increased emphasis on outcomes-based healthcare, and a growing utilization of real-world data in clinical research. Key trends expected during the same period encompass the growing uptake of integrated disease registry platforms, increased reliance on cloud-based patient data management, an intensified focus on regulatory-compliant data reporting, the broadening of EHR-integrated registry solutions, and a stronger emphasis on gathering real-world evidence.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/disease-registry-software-global-market-report

Which Key Drivers Are Affecting The Disease Registry Software Market Development?

The increasing embrace of personalized medicine is projected to drive the growth of the disease registry software market moving forward. Personalized medicine refers to a medical strategy that customizes treatment and prevention plans for an individual based on their unique genetic composition, lifestyle, and environment. The rising adoption of personalized medicine is primarily attributed to advancements in genomics, which allow for the precise identification of genetic variations and the development of tailored treatments for individuals. Disease registry software aids personalized medicine by systematically collecting and managing patient health data, thereby facilitating customized treatment plans and enhancing clinical decision-making. This software also streamlines data access and analysis, improving patient outcomes and furthering precision healthcare. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, marking a significant increase from the 12 approved in 2022. Therefore, the expanding adoption of personalized medicine is propelling the growth of the disease registry software market.

How Are Segments Identified Within The Disease Registry Software Market Segment Framework?

The disease registry software market covered in this report is segmented –

1) By Type: Standalone, Integrated

2) By Database: Public, Commercial

3) By Deployment Mode: On-Premises, Cloud-Based

4) By End-User: Hospitals, Government Organizations, Research Centers, Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Standalone: Patient Registry Software, Population Health Registry Software, Research Registry Software, Custom Or Single-Disease Registry Software

2) By Integrated: Electronic Health Record (EHR)-Integrated Registry Software, Practice Management System-Integrated Registry Software, Clinical Decision Support (CDS)-Integrated Registry Software, Health Information Exchange (HIE)-Integrated Registry Software

What Trends Are Transforming The Disease Registry Software Market?

Companies operating within the disease registry software market are increasingly concentrating on the development of patient-centric registries, including digital registers, designed to track outcomes and facilitate personalized care. These digital registers are electronic systems or software platforms that systematically gather, store, and manage patient health information, effectively replacing traditional paper-based registries. For example, in August 2025, the American College of Cardiology (ACC), a US-based nonprofit medical association, launched its CONNECT-HCM Registry. This nationwide digital registry is intended to improve the understanding and management of hypertrophic cardiomyopathy (HCM), which stands as the most common genetic cardiovascular disease. The registry allows for direct patient enrollment beyond individual centers, thereby addressing long-standing gaps in diagnosis and care. Furthermore, this platform integrates registry data with electronic health records via Arboretum’s Hugo Connect platform, aiding researchers in monitoring symptoms, imaging, treatments, and outcomes over time.

Who Are The Companies Competing Within The Disease Registry Software Market?

Major companies operating in the disease registry software market are Optum Inc., IQVIA Holdings Inc., Syneos Health Inc., Epic Systems Corporation, Premier Inc., MRO Corp., ImageTrend Inc., Anju Software Inc., BayaTree Inc., Medrio Inc., ArborMetrix Inc., Cedaron Medical Inc., Evado Pty. Ltd., OpenClinica LLC, Dacima Software Inc., Global Vision Technologies Inc., Ordinal Data Inc., Healthmonix LLC, Axis Clinical Software Inc., Vanderbilt University

Get The Full Disease Registry Software Market Report:

https://www.thebusinessresearchcompany.com/report/disease-registry-software-global-market-report

Which Region Is The Largest In The Disease Registry Software Market?

North America was the largest region in the disease registry software market in 2025. The regions covered in the disease registry software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Disease Registry Software Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/disease-registry-software-global-market-report

Browse Through More Reports Similar to the Global Disease Registry Software Market 2026, By The Business Research Company

Healthcare Compliance Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/healthcare-compliance-software-global-market-report

Disease Management Apps Market Report 2026

https://www.thebusinessresearchcompany.com/report/disease-management-apps-global-market-report

Personal Health Record Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/personal-health-record-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Disease Registry Software Market From 2026 To 2030?

The disease registry software market has shown rapid expansion in recent years. This market is projected to increase from $1.55 billion in 2025 to $1.73 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.4%. Historically, this growth can be attributed to several factors including the rising digitization of patient records, the proliferation of disease-specific research programs, stricter regulatory reporting requirements, the wider adoption of electronic health records, and the increasing application of data-driven clinical decision tools.

The disease registry software market is anticipated to experience substantial expansion over the upcoming years, reaching a size of $2.64 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.1%. This expansion during the forecast period is fueled by several factors, including a heightened demand for population health analytics, greater integration with AI-driven clinical insights, the broader deployment of cloud-based registries, an increased emphasis on outcomes-based healthcare, and a growing utilization of real-world data in clinical research. Key trends expected during the same period encompass the growing uptake of integrated disease registry platforms, increased reliance on cloud-based patient data management, an intensified focus on regulatory-compliant data reporting, the broadening of EHR-integrated registry solutions, and a stronger emphasis on gathering real-world evidence.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/disease-registry-software-global-market-report

Which Key Drivers Are Affecting The Disease Registry Software Market Development?

The increasing embrace of personalized medicine is projected to drive the growth of the disease registry software market moving forward. Personalized medicine refers to a medical strategy that customizes treatment and prevention plans for an individual based on their unique genetic composition, lifestyle, and environment. The rising adoption of personalized medicine is primarily attributed to advancements in genomics, which allow for the precise identification of genetic variations and the development of tailored treatments for individuals. Disease registry software aids personalized medicine by systematically collecting and managing patient health data, thereby facilitating customized treatment plans and enhancing clinical decision-making. This software also streamlines data access and analysis, improving patient outcomes and furthering precision healthcare. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, marking a significant increase from the 12 approved in 2022. Therefore, the expanding adoption of personalized medicine is propelling the growth of the disease registry software market.

How Are Segments Identified Within The Disease Registry Software Market Segment Framework?

The disease registry software market covered in this report is segmented –

1) By Type: Standalone, Integrated

2) By Database: Public, Commercial

3) By Deployment Mode: On-Premises, Cloud-Based

4) By End-User: Hospitals, Government Organizations, Research Centers, Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Standalone: Patient Registry Software, Population Health Registry Software, Research Registry Software, Custom Or Single-Disease Registry Software

2) By Integrated: Electronic Health Record (EHR)-Integrated Registry Software, Practice Management System-Integrated Registry Software, Clinical Decision Support (CDS)-Integrated Registry Software, Health Information Exchange (HIE)-Integrated Registry Software

What Trends Are Transforming The Disease Registry Software Market?

Companies operating within the disease registry software market are increasingly concentrating on the development of patient-centric registries, including digital registers, designed to track outcomes and facilitate personalized care. These digital registers are electronic systems or software platforms that systematically gather, store, and manage patient health information, effectively replacing traditional paper-based registries. For example, in August 2025, the American College of Cardiology (ACC), a US-based nonprofit medical association, launched its CONNECT-HCM Registry. This nationwide digital registry is intended to improve the understanding and management of hypertrophic cardiomyopathy (HCM), which stands as the most common genetic cardiovascular disease. The registry allows for direct patient enrollment beyond individual centers, thereby addressing long-standing gaps in diagnosis and care. Furthermore, this platform integrates registry data with electronic health records via Arboretum’s Hugo Connect platform, aiding researchers in monitoring symptoms, imaging, treatments, and outcomes over time.

Who Are The Companies Competing Within The Disease Registry Software Market?

Major companies operating in the disease registry software market are Optum Inc., IQVIA Holdings Inc., Syneos Health Inc., Epic Systems Corporation, Premier Inc., MRO Corp., ImageTrend Inc., Anju Software Inc., BayaTree Inc., Medrio Inc., ArborMetrix Inc., Cedaron Medical Inc., Evado Pty. Ltd., OpenClinica LLC, Dacima Software Inc., Global Vision Technologies Inc., Ordinal Data Inc., Healthmonix LLC, Axis Clinical Software Inc., Vanderbilt University

Get The Full Disease Registry Software Market Report:

https://www.thebusinessresearchcompany.com/report/disease-registry-software-global-market-report

Which Region Is The Largest In The Disease Registry Software Market?

North America was the largest region in the disease registry software market in 2025. The regions covered in the disease registry software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Disease Registry Software Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/disease-registry-software-global-market-report

Browse Through More Reports Similar to the Global Disease Registry Software Market 2026, By The Business Research Company

Healthcare Compliance Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/healthcare-compliance-software-global-market-report

Disease Management Apps Market Report 2026

https://www.thebusinessresearchcompany.com/report/disease-management-apps-global-market-report

Personal Health Record Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/personal-health-record-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Disease Registry Software Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The disease registry software market has experienced significant expansion in recent years. This market is set to increase from $1.55 billion in 2025 to $1.73 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.4%. Contributing factors to this historical growth include the escalating digitization of patient records, the enlargement of disease-specific research programs, heightened regulatory reporting requirements, the widespread adoption of electronic health records, and the increasing reliance on data-driven clinical decision tools.

The disease registry software market is projected for substantial expansion in the coming years. This market is set to reach $2.64 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.1%. This anticipated growth is driven by factors such as a heightened need for population health analytics, increased integration with AI-powered clinical insights, wider deployment of cloud-based registries, an intensified emphasis on outcomes-based healthcare, and greater utilization of real-world data in clinical studies. Key trends for this period encompass the growing adoption of integrated disease registry platforms, increased reliance on cloud-based patient data management, a heightened focus on regulatory-compliant data reporting, the broadening of EHR-integrated registry solutions, and a stronger emphasis on gathering real-world evidence.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28208&type=smp

What Drivers Are Influencing The Disease Registry Software Market?

The growing embrace of personalized medicine is projected to stimulate the expansion of the disease registry software market in the future. Personalized medicine defines a medical methodology that customizes treatment and prevention strategies based on an individual’s distinct genetic composition, way of life, and environment. This rise in personalized medicine adoption is primarily attributed to breakthroughs in genomics, which facilitate accurate identification of genetic variations and personalized therapeutic interventions. Disease registry software plays a crucial role in supporting personalized medicine by systematically gathering and organizing patient health information, thereby enabling customized treatment approaches and better clinical choices. It also simplifies access to and analysis of data, which improves patient results and advances precision healthcare. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) cleared 26 new personalized medicines in 2023, which is a considerable jump from the 12 approved in 2022. Consequently, the increasing adoption of personalized medicine is accelerating the growth of the disease registry software market.

What Major Segment Divisions Exist Within The Disease Registry Software Market?

The disease registry software market covered in this report is segmented –

1) By Type: Standalone, Integrated

2) By Database: Public, Commercial

3) By Deployment Mode: On-Premises, Cloud-Based

4) By End-User: Hospitals, Government Organizations, Research Centers, Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Standalone: Patient Registry Software, Population Health Registry Software, Research Registry Software, Custom Or Single-Disease Registry Software

2) By Integrated: Electronic Health Record (EHR)-Integrated Registry Software, Practice Management System-Integrated Registry Software, Clinical Decision Support (CDS)-Integrated Registry Software, Health Information Exchange (HIE)-Integrated Registry Software

Which Trends Are Shaping The Future Of The Disease Registry Software Market?

Leading firms within the disease registry software sector are prioritizing the creation of patient-focused registries, including digital solutions, to monitor outcomes and facilitate tailored care. These digital registers represent electronic systems or software platforms designed for the systematic collection, storage, and management of patient health data, thereby substituting conventional paper-based records. An example is the launch of the CONNECT-HCM Registry by the American College of Cardiology (ACC), a US-based nonprofit medical association, in August 2025. This nationwide digital registry aims to enhance comprehension and treatment of hypertrophic cardiomyopathy (HCM), which is the most prevalent genetic cardiovascular condition. It allows patients to enroll directly from various locations, not just individual centers, thereby filling persistent gaps in diagnosis and care. The platform integrates its registry information with electronic health records through Arboretum’s Hugo Connect platform, assisting researchers in monitoring symptoms, imaging results, treatments, and patient outcomes across an extended period.

Which Companies Are Leading Innovation In The Disease Registry Software Market?

Major companies operating in the disease registry software market are Optum Inc., IQVIA Holdings Inc., Syneos Health Inc., Epic Systems Corporation, Premier Inc., MRO Corp., ImageTrend Inc., Anju Software Inc., BayaTree Inc., Medrio Inc., ArborMetrix Inc., Cedaron Medical Inc., Evado Pty. Ltd., OpenClinica LLC, Dacima Software Inc., Global Vision Technologies Inc., Ordinal Data Inc., Healthmonix LLC, Axis Clinical Software Inc., Vanderbilt University

Read the full disease registry software market report here:

https://www.thebusinessresearchcompany.com/report/disease-registry-software-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Disease Registry Software Market?

North America was the largest region in the disease registry software market in 2025. The regions covered in the disease registry software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Disease Registry Software Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28208&type=smp

Browse Through More Reports Similar to the Global Disease Registry Software Market 2026, By The Business Research Company

Disease Management Apps Global Market Report

https://www.thebusinessresearchcompany.com/report/disease-management-apps-global-market-report

Personal Health Record Software Global Market Report

https://www.thebusinessresearchcompany.com/report/personal-health-record-software-global-market-report

Healthcare Compliance Software Global Market Report

https://www.thebusinessresearchcompany.com/report/healthcare-compliance-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model